[96a5a0]: / output / allTrials / identified / NCT00520676_identified.json

Download this file

231 lines (231 with data), 9.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
{
"info": {
"nct_id": "NCT00520676",
"official_title": "A Randomized Phase 3 Study Comparing Pemetrexed-Carboplatin With Docetaxel-Carboplatin as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
"inclusion_criteria": "* Patient with locally advanced or metastatic (Stage IIIB/IV) NCSLC with no prior chemotherapy for advanced disease or molecular target treatment\n* Easter Cooperative Oncology Group (ECOG) performance status 0 to 2\n* Estimated life expectancy of at least 8 weeks\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Known or suspected brain metastases\n* Concurrent administration of any other tumor therapy\n* Serious concomitant disorders\n* Pregnancy or breast feeding\n* Inability or unwillingness to take folic acid or vitamin B12 supplementation",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patient with locally advanced or metastatic (Stage IIIB/IV) NCSLC with no prior chemotherapy for advanced disease or molecular target treatment",
"criterions": [
{
"exact_snippets": "locally advanced or metastatic (Stage IIIB/IV) NCSLC",
"criterion": "NCSLC stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"Stage IIIB",
"Stage IV"
]
}
]
},
{
"exact_snippets": "no prior chemotherapy for advanced disease",
"criterion": "prior chemotherapy for advanced disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "no prior ... molecular target treatment",
"criterion": "prior molecular target treatment",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Easter Cooperative Oncology Group (ECOG) performance status 0 to 2",
"criterions": [
{
"exact_snippets": "Easter Cooperative Oncology Group (ECOG) performance status 0 to 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Estimated life expectancy of at least 8 weeks",
"criterions": [
{
"exact_snippets": "Estimated life expectancy of at least 8 weeks",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Known or suspected brain metastases",
"criterions": [
{
"exact_snippets": "Known or suspected brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Concurrent administration of any other tumor therapy",
"criterions": [
{
"exact_snippets": "Concurrent administration of any other tumor therapy",
"criterion": "concurrent tumor therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Serious concomitant disorders",
"criterions": [
{
"exact_snippets": "Serious concomitant disorders",
"criterion": "concomitant disorders",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
}
]
}
]
},
{
"line": "* Pregnancy or breast feeding",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breast feeding",
"criterion": "breast feeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Inability or unwillingness to take folic acid or vitamin B12 supplementation",
"criterions": [
{
"exact_snippets": "Inability or unwillingness to take folic acid",
"criterion": "folic acid supplementation",
"requirements": [
{
"requirement_type": "ability or willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "Inability or unwillingness to take ... vitamin B12 supplementation",
"criterion": "vitamin B12 supplementation",
"requirements": [
{
"requirement_type": "ability or willingness",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}